Authorized purpose: Swoop Portable MR Imaging System is a portable ultra-low-field MR system for point-of-care head imaging in adult and pediatric patients when a conventional full diagnostic MRI examination is impractical.
Clinical role
Point-of-care head MRI acquisition and reconstruction for professional interpretation when a conventional MRI examination is impractical.
Images and patients
MRI · Brain
Key limitation
Keep in mind: The Swoop Portable MR Imaging System is a portable, ultra-low field magnetic resonance imaging device for producing images that display the internal structure of the head where full diagnostic examination is not clinically practical. When interpreted by a trained physician, these images provide information that can be useful in determining a diagnosis.
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
What does this software do?Authorized purpose: Swoop Portable MR Imaging System is a portable ultra-low-field MR system for point-of-care head imaging in adult and pediatric patients when a conventional full diagnostic MRI examination is impractical.
Which images or clinical context are in scope?Modality: MRI Anatomy or clinical context: Brain Input: MRI image data
Who uses it?Intended users: trained physician
What does the software produce?Output: The system can generate MRI data sets with a broad range of contrasts.
What is its most important limitation?Key limitation: The Swoop Portable MR Imaging System is a portable, ultra-low field magnetic resonance imaging device for producing images that display the internal structure of the head where full diagnostic examination is not clinically practical. When interpreted by a trained physician, these images provide information that can be useful in determining a diagnosis.
Clinical takeaway. Clinical role: Swoop Portable MR Imaging System is a portable ultra-low-field MR system for point-of-care head imaging in adult and pediatric patients when a conventional full diagnostic MRI examination is impractical.
Evidence takeaway. Evidence from the reviewed source record: The exact FDA document reports non-clinical testing chosen by a risk-based assessment of the modifications: software verification, image performance testing against image quality criteria, cybersecurity testing, and software validation; the device passed all testing. Other test results were leveraged from the predicate device. No clinical study results are reported. Results are as reported in the FDA submission, not independent validation.
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
Swoop Portable MR Imaging System is a portable ultra-low-field MR system for point-of-care head imaging in adult and pediatric patients when a conventional full diagnostic MRI examination is impractical.
Exact FDA submission
Checked 2026-09-19
Clinical-use display mirrors the exact FDA-supported purpose reconciled from the decision-summary packet.
The Swoop Portable MR Imaging System is a portable, ultra-low field magnetic resonance imaging device for producing images that display the internal structure of the head where full diagnostic examination is not clinically practical. When interpreted by a trained physician, these images provide information that can be useful in determining a diagnosis.
Exact FDA submission
Checked 2026-09-19
This replaces the dossier's unsupported conventional-MRI replacement statement with the packet's indication and interpretation boundary.
The exact FDA document reports non-clinical testing chosen by a risk-based assessment of the modifications: software verification, image performance testing against image quality criteria, cybersecurity testing, and software validation; the device passed all testing. Other test results were leveraged from the predicate device. No clinical study results are reported. Results are as reported in the FDA submission, not independent validation.
Exact FDA submission
Checked 2026-11-14
Packet wording: "Based on the risk assessment, the following testing was performed. The subject device passed all the testing in accordance with internal requirements and applicable standards to support substantial equivalence." … "IEC 62304:2015 Software verification testing in accordance with". Read from the exact FDA decision document on 2026-11-14.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
The exact FDA document reports non-clinical testing chosen by a risk-based assessment of the modifications: software verification, image performance testing against image quality criteria, cybersecurity testing, and software validation; the device passed all testing. Other test results were leveraged from the predicate device. No clinical study results are reported. Results are as reported in the FDA submission, not independent validation.
FDA source
Exact FDA submission
Checked 2026-11-14
Packet wording: "Based on the risk assessment, the following testing was performed. The subject device passed all the testing in accordance with internal requirements and applicable standards to support substantial equivalence." … "IEC 62304:2015 Software verification testing in accordance with". Read from the exact FDA decision document on 2026-11-14.
Sensitivity is not the primary endpoint for this system, reconstruction, segmentation, guidance, or quantitative function. Use the task-specific evidence below.
Reported specificity
Not applicable
Not applicable
Not applicable
Checked 2026-09-03
Specificity is not the primary endpoint for this system, reconstruction, segmentation, guidance, or quantitative function. Use the task-specific evidence below.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
K240944 FDA performance package for Swoop® Portable MR Imaging® System
DesignManufacturer portable-MR system, reconstruction, image-quality, safety, and clinical-image validation
PopulationPediatric and adult point-of-care head MRI applications
Scopeexact submission
Tested versionSwoop Portable MR Imaging System
IndependenceSponsor or vendor study
K240944
Manufacturer evidence submitted for FDA clearance or approval; local clinical, technical, and workflow acceptance remains necessary.
1 unlinked candidate evidence record is retained for source review and excluded from this evidence display.
Safety and lifecycle
Postmarket record
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
The 2026-09-02 openFDA device-recall snapshot contained no record matched to K240944 by exact submission identifier. This does not exclude product-family, later, or adverse-event information.
Public source
Exact FDA submission
Checked 2026-09-03
Exact-identifier review does not prove absence of all product-family safety signals.
No separate named-product Medicare payment was identified in the reviewed CMS coverage material. Evaluate the product within the applicable imaging, procedural, or surgical service line and verify payer, site-of-service, and coding assumptions independently.
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: MRI image data
Scope: Exact FDA submission. The packet names MRI image data, but does not state the dossier's signal-data, coil, and sequence input wording as a direct device-input claim.
Confirm scanner/model, protocol, series completeness and both software builds.
Source context, not route validation: Portable scanner and console workflow with DICOM export to a PACS or workstation; validate identifiers, series labels, image orientation, routing, and archive completion.
Scope: Product family. Current vendor materials are product-family evidence for K240944; confirm the exact cleared version, enabled options, deployment, and local compatibility.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Source context, not route validation: Portable MRI hardware, control device, console software, and release-specific reconstruction software deployed at the point of care.
Scope: Product family. Current vendor materials are product-family evidence for K240944; confirm the exact cleared version, enabled options, deployment, and local compatibility.
Confirm processing location, queue ownership, exclusions and exact AI build.
Unresolved route: The system can generate MRI data sets with a broad range of contrasts.
Scope: Exact FDA submission. The packet states MRI data sets and DICOM output; it does not state archival output as written in the dossier.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
Portable MRI hardware, control device, console software, and release-specific reconstruction software deployed at the point of care.
Product family
Checked 2026-09-03
Current vendor materials are product-family evidence for K240944; confirm the exact cleared version, enabled options, deployment, and local compatibility.
Portable scanner and console workflow with DICOM export to a PACS or workstation; validate identifiers, series labels, image orientation, routing, and archive completion.
Product family
Checked 2026-09-03
Current vendor materials are product-family evidence for K240944; confirm the exact cleared version, enabled options, deployment, and local compatibility.
Hyperfine's current certifications page says the Swoop System device services, security services and Hyperfine PACS services (hosted on AWS, Ashburn, Virginia) meet HITRUST CSF v9.4 r2 criteria, and that a SOC 2 Type II report on the Swoop system (security criteria only) is available under NDA. The page gives no certification dates; neither report was read.
Vendor-wide
Checked 2026-10-25
Vendor-wide statement, not an independent attestation. It does not establish certificate or report scope for this exact release, expiry, data location, retention, identity and access, or incident-response terms for a deployed configuration. Obtain these from the vendor.
Only trained physicians and mri technologists working within the labeled portable-mr workflow should operate or interpret the product. Local onboarding should cover the exact release, supported population, limitations, failure examples, escalation, downtime, and competency documentation.
Monitor by exact hardware, software, model, and algorithm version; patient population; anatomy; protocol; operator; input quality; output edits or overrides; failed studies; repeat acquisition or rework; downstream impact; downtime; incidents; recalls; and updates. Track these product-specific limits: Use only the cleared head-imaging workflow and supported hardware, coils, sequences, patient populations, and operating conditions; low-field images require professional interpretation and do not replace a conventional diagnostic MRI examination when that examination is available.
Product family
Checked 2026-09-03
Current vendor materials are product-family evidence for K240944; confirm the exact cleared version, enabled options, deployment, and local compatibility.
Portable scanner and console workflow with DICOM export to a PACS or workstation; validate identifiers, series labels, image orientation, routing, and archive completion.
product family · checked 2026-09-03
Test representative identifiers, orientation, geometry, measurements, units, routing, failure handling, and round trips locally. Vendor statements are current product-family context; confirm the exact cleared release and installed options.
Use a signed local test set for the supported population and workflow. Include common and difficult cases, exclusions, acquisition variation, failed or low-quality inputs, reviewer overrides, and downstream effects. Use only the cleared head-imaging workflow and supported hardware, coils, sequences, patient populations, and operating conditions; low-field images require professional interpretation and do not replace a conventional diagnostic MRI examination when that examination is available.
exact submission · checked 2026-09-03
Define stop-use, escalation, rollback, and revalidation triggers before production use.
Model capital and recurring cost against net staff time after review, throughput, repeat imaging or rework, room time, consumables, infrastructure, training, service, downtime, upgrade, and replacement costs.
product family · checked 2026-09-03
No exact-product price was found in the reviewed public material; vendor productivity claims are scenario inputs, not guaranteed local savings.
Monitor by exact hardware, software, model, and algorithm version; patient population; anatomy; protocol; operator; input quality; output edits or overrides; failed studies; repeat acquisition or rework; downstream impact; downtime; incidents; recalls; and updates. Track these product-specific limits: Use only the cleared head-imaging workflow and supported hardware, coils, sequences, patient populations, and operating conditions; low-field images require professional interpretation and do not replace a conventional diagnostic MRI examination when that examination is available.
product family · checked 2026-09-03
Revalidate after material software, hardware, model, protocol, interface, or clinical-policy changes. Vendor statements are current product-family context; confirm the exact cleared release and installed options.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
The exact packet identifies the anatomical site as Head; the dossier's narrower Brain label is not the packet wording. Controlled directory display reconciled from exact FDA wording: Head -> Brain.
This audit distinguishes completed source review from fields that have not yet been researched.
Exact FDA record reviewedStatus
2026-09-20Last searched
28Fields reviewed
14Source classes checked
0Screened PubMed leads
1Screened trial leads
0Unreviewed FDA recall leads
The refreshed discovery snapshot contains 0 PubMed and 1 ClinicalTrials.gov candidate record. Discovery metadata alone does not establish exact tested-product, version, population, and endpoint applicability, so all candidates remain quarantined and none was promoted. The current discovery snapshot contains 0 PubMed and 1 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, fda decision material, vendor product page, peer reviewed literature, clinical trial registry, reimbursement policy, fda device recall, fda decision summary packet, literature index, trial registry, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Public pricing: Not publicly available - checked 2026-09-03 - Exact FDA submission
No public list price for the exact cleared configuration was found. Obtain a written quote separating hardware or license basis, implementation, interfaces, infrastructure, training, service, upgrades, renewal, consumables, and exit costs.
Authorized purpose: ANDI 2.2 processes brain MR images for atlas-assisted visualization, segmentation and volumetric quantification, presenting adjunctive DICOM-readable information for trained medical professionals; it does not predict, diagnose or interpret brain health.
Authorized purpose: Morph automatically labels, visualizes, and volumetrically quantifies segmentable brain structures from MR images and may compare measurements with reference percentile data; it is adjunctive and not the sole basis for final decisions.
Authorized purpose: Brain MRI morphometry and white matter hyperintensity quantification, including normative comparison and longitudinal change assessment for clinician review.
Authorized purpose: Swoop Portable MR Imaging System provides ultra-low-field point-of-care head MRI for all ages and includes deep-learning T1, T2, FLAIR, and DWI reconstruction.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.